Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2016

01-12-2016 | Erratum

Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient

Authors: Thomas M. Churilla, Brian L. Egleston, Colin T. Murphy, Elin R. Sigurdson, Shelly B. Hayes, Lori J. Goldstein, Richard J. Bleicher

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Excerpt

In the original publication of the article, the last two sentences in the results of abstract were published incorrectly. The corrected sentences should read as below: …
Metadata
Title
Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient
Authors
Thomas M. Churilla
Brian L. Egleston
Colin T. Murphy
Elin R. Sigurdson
Shelly B. Hayes
Lori J. Goldstein
Richard J. Bleicher
Publication date
01-12-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-4023-5

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue

Clinical trial

Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems

Epidemiology

Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients

Epidemiology

Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk

Epidemiology

Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race

Epidemiology

Investigation of breast cancer sub-populations in black and white women in South Africa

Clinical Trial

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits